Aker BioMarine
Leading supplier of sustainably sourced Antarctic krill ingredients for human health and nutrition.
AKBM | OL
Overview
Corporate Details
- ISIN(s):
- NO0010886625 (+1 more)
- LEI:
- 549300V34T6VWDSYWE64
- Country:
- Norway
- Address:
- Oksenøyveien 10, 1366 Lysaker
- Website:
- https://www.akerbiomarine.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of vegetable and animal oils and fats
Description
Aker BioMarine is a biotechnology innovator and the world's leading supplier of krill-based ingredients sourced from the Antarctic. The company specializes in the research, development, and manufacturing of krill-derived products for the human health and nutrition markets, with a focus on nutraceutical applications like omega-3 supplements. A key differentiator is its vertically integrated value chain, which ensures full traceability and control from sustainable harvesting in the Southern Ocean to the final ingredient. Aker BioMarine leverages scientific research to develop its portfolio of natural ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-05 14:52 |
Director's Dealing
MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER - Attachment: Skjema for mel…
|
Norwegian | 128.4 KB | ||
| 2025-11-05 14:52 |
Director's Dealing
MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
|
English | 1.8 KB | ||
| 2025-11-05 09:50 |
Director's Dealing
MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER - Attachment: Skjema for mel…
|
Norwegian | 128.8 KB | ||
| 2025-11-05 09:50 |
Director's Dealing
MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
|
English | 1.8 KB | ||
| 2025-10-31 07:00 |
Investor Presentation
Third quarter 2025 results for Aker BioMarine - Attachment: Aker BioMarine Q3 2…
|
English | 2.0 MB | ||
| 2025-10-31 07:00 |
Earnings Release
Third quarter 2025 results for Aker BioMarine
|
English | 4.2 KB | ||
| 2025-10-28 17:34 |
Report Publication Announcement
Aker BioMarine ASA – Invitation to presentation of the third quarter 2025 resul…
|
English | 1.8 KB | ||
| 2025-09-10 13:55 |
Interest Rate Update/Notice
Rentefastsettelse - Attachment: adcf0c6edcec4d98a172592dc9018192.pdf
|
Norwegian | 44.0 KB | ||
| 2025-09-10 13:55 |
Interest Rate Update/Notice
Rentefastsettelse
|
Norwegian | 532 bytes | ||
| 2025-07-18 14:55 |
Director's Dealing
AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER - Attachment: Skjema f…
|
Norwegian | 130.4 KB | ||
| 2025-07-18 14:55 |
Director's Dealing
AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
|
English | 1.7 KB | ||
| 2025-07-11 07:00 |
Interim Report
Second quarter 2025 results for Aker BioMarine - Attachment: AKBM 1H report 202…
|
English | 1.2 MB | ||
| 2025-07-11 07:00 |
Investor Presentation
Second quarter 2025 results for Aker BioMarine - Attachment: Aker BioMarine Q2 …
|
English | 1.4 MB | ||
| 2025-07-11 07:00 |
Earnings Release
Second quarter 2025 results for Aker BioMarine
|
English | 4.1 KB | ||
| 2025-06-20 16:48 |
Capital/Financing Update
Euronext Oslo Børs – Aker BioMarine ASA - Mottatt søknad om notering av obligas…
|
Norwegian | 572 bytes |
Automate Your Workflow. Get a real-time feed of all Aker BioMarine filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aker BioMarine
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aker BioMarine via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
